Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Johnson & Johnson
JNJ
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$164.95
0.13
0.08%
Pre-Market: 7:49 PM EDT
15 minutes delayed
Get Report
Comment
Johnson & Johnson (JNJ) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Johnson & Johnson (NYSE:JNJ) Stock
Johnson & Johnson Stock (NYSE: JNJ)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, September 20, 2024
Johnson & Johnson Announces FDA Approval Of R...
Benzinga Newsdesk
Thursday, September 19, 2024
The Latest Analyst Ratings For Johnson & Johnson
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Jo...
Benzinga Newsdesk
Wednesday, September 18, 2024
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
Vandana Singh
Monday, September 16, 2024
Cantor Fitzgerald Reiterates Overweight on Jo...
Benzinga Newsdesk
Reported Saturday, Johnson & Johnson Shares N...
Benzinga Newsdesk
Reported Sunday, Johnson & Johnson Reveals Ne...
Benzinga Newsdesk
Johnson & Johnson's TAR-200 Plus Cetrelimab N...
Benzinga Newsdesk
Thursday, September 12, 2024
Unpacking the Latest Options Trading Trends in Johnson & Johnson
Benzinga Insights
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
Benzinga Insights
Johnson & Johnson Seeks First EU Approval Of ...
Benzinga Newsdesk
How To Earn $500 A Month From Johnson & Johnson Stock
Avi Kapoor
Reported Earlier, FDA Approves Johnson & John...
Benzinga Newsdesk
Wednesday, September 11, 2024
Metals in Tampons: FDA Initiates New Safety Measures and Testing
Vandana Singh
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
Vandana Singh
Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
Vandana Singh
Tuesday, September 10, 2024
Johnson & Johnson Says Dexamethasone Reduces ...
Benzinga Newsdesk
FDA Says Aware Of Concerns About Tampon Safet...
Benzinga Newsdesk
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Vandana Singh
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
Surbhi Jain
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Jo...
Benzinga Newsdesk
Reported Sunday, Johnson & Johnson Unveils Lo...
Benzinga Newsdesk
Friday, September 06, 2024
Dell, CoStar, PayPal And A Major Health Care Stock On CNBC's 'Final Trades'
Avi Kapoor
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Avi Kapoor
Thursday, September 05, 2024
Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory
Vandana Singh
CNBC Halftime Report Final Trades: PayPal, Jo...
Benzinga Newsdesk
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Juan Spínelli
Wednesday, September 04, 2024
"Johnson & Johnson Wins Over Longtime Holdout...
Benzinga Newsdesk
Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B
Vandana Singh
Delaware Judge Rules Johnson & Johnson Owes A...
Benzinga Newsdesk
Tuesday, September 03, 2024
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
Vandana Singh
Critical Insights From Johnson & Johnson Analyst Ratings: What You Need To Know
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Jo...
Benzinga Newsdesk
Friday, August 30, 2024
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
Vandana Singh
Thursday, August 29, 2024
Johnson & Johnson's Golden Cross: A Bullish Prescription For Investors?
Surbhi Jain
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
Vandana Singh
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
Benzinga Insights
Johnson & Johnson Seeks First Approval Of Nip...
Benzinga Newsdesk
Wednesday, August 28, 2024
'AHA Urges HRSA To Take Immediate Enforcement...
Benzinga Newsdesk
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
Benzinga Insights
Tuesday, August 27, 2024
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
Vandana Singh
Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods
Avi Kapoor
Monday, August 26, 2024
Johnson & Johnson Aims New Policy For Hospital Payments Under 340B Drug Discount Program Related To Its Flagship Blood Thinner And Arthritis Drugs
Vandana Singh
Johnson & Johnson Seeks Resolution With Plaintiffs, Pushes To Finalize $6.5B Talc Settlement
Vandana Singh
Friday, August 23, 2024
Johnson & Johnson Says European Commission Ap...
Benzinga Newsdesk
U.S. CDC Says For This Season Peak Hospitaliz...
Benzinga Newsdesk
Tuesday, August 20, 2024
WHO Official Hans Kluge Asserts Mpox Is Not T...
Benzinga Newsdesk
Johnson & Johnson Strikes $1.7B Deal To Acquire Heart-Tech Innovator V-Wave
Vandana Singh
Johnson & Johnson to Acquire Cardiovascular T...
Benzinga Newsdesk
Johnson & Johnson Secures FDA Nod for New Lun...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch